Cargando…
Human antibodies reactive with beta-amyloid protein in Alzheimer's disease
Four human B cell lines established by Epstein-Barr viral transformation of B cells from a patient with a clinical diagnosis of Alzheimer's disease (AD) were found to secrete antibodies that react with plaques and cerebrovascular blood vessels in AD brain in a staining profile characteristic of...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190957/ https://www.ncbi.nlm.nih.gov/pubmed/8459212 |
Ejemplares similares
-
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
por: Hunter, Sally, et al.
Publicado: (2017) -
Erratum to: Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
por: Hunter, Sally, et al.
Publicado: (2017) -
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
por: Gibbs, Ebrima, et al.
Publicado: (2019) -
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
por: Sehlin, Dag, et al.
Publicado: (2016) -
Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)